Market Cap

Galecto, Inc. Market Capitalization:

$19.2 Million

USD as of Jan. 1, 2024

business Galecto, Inc. Company Profile

Galecto, Inc. Main Stock Listing

NASDAQ: GLTO

Market Capitalization History of Galecto, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Galecto, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $19.2 M -62.35%
Jan. 1, 2023 $50.9 M -22.08%
Jan. 1, 2022 $65.3 M -80.63%
Jan. 1, 2021 $337.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Galecto, Inc. Categories

Denmark languages Healthcare languages Biotechnology
Denmark Healthcare Denmark Biotechnology

Stocks & Indices

Galecto, Inc. has the following listings and related stock indices.


Stock: NASDAQ: GLTO

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.